ACLARION, INC. Proceeds from Other Debt
ACLARION, INC. (ACON) reported Proceeds from Other Debt of $2.00 million for the 9-month period ending 2023-09-30, per its 10-Q filed 2023-11-14.
Discontinued › Cash Flow › Financing Activities
us-gaap:ProceedsFromOtherDebt · last filed 2023-11-14
- ACLARION, INC. proceeds from other debt for the quarter ending 2023-09-30 was $750.00K.
- ACLARION, INC. proceeds from other debt for the quarter ending 2022-09-30 was $0.00.
| Period end | Proceeds from Other Debt 3 month | Proceeds from Other Debt 6 month | Proceeds from Other Debt 9 month |
|---|---|---|---|
| 2023-09-30 | $750.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-14 | $2.00M 10-Q · filed 2023-11-14 | |
| 2023-06-30 | $1.25M 10-Q · filed 2023-08-25 | ||
| 2022-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-14 | $0.00 10-Q · filed 2023-11-14 | |
| 2022-06-30 | $0.00 10-Q · filed 2023-08-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Advanced Biomed Inc. (ADVB) | $0.009B | ||
| AMERICAN SHARED HOSPITAL SERVICES (AMS) | United States | $0.010B | -5.64 |
| BioNexus Gene Lab Corp (BGLC) | $0.004B | ||
| SERA PROGNOSTICS, INC. (SERA) | United States | $0.062B | -5.75 |
| Freenome, Inc. (FRNM) | United States | $0.143B | |
| EXAGEN INC. (XGN) | United States | $0.212B | -5.95 |
| BIODESIX INC (BDSX) | United States | $0.312B | |
| Fulgent Genetics, Inc. (FLGT) | United States | $0.593B | -6.70 |
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| CASTLE BIOSCIENCES INC (CSTL) | United States | $1.074B | -37.45 |